Glioma is a prevalent primary tumor of the brain and spinal cord. Several biological pathways
play an important role in the pathogenesis of glioma, including apoptosis, autophagy, cell cycle
arrest, migration, and invasion. The low efficacy of chemotherapy and radiation therapy has forced
researchers to evaluate alternative treatments for glioma. In this regard, flavonoids have been studied.
Resveratrol is a flavonoid with distinct pharmacological activities that has been used in the treatment
of various diseases. Several recent studies have also focused on its therapeutic efficacy against glioma.
Resveratrol exerts its pharmacological attributes by regulating various molecular and cellular
pathways. Here, we review contemporary knowledge in support of the use of resveratrol in the treatment
of glioma and its effects on various molecular and cellular mechanisms.